Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 60

Sort by

Sort Order Select

Journal Articles

Clonal Hematopoiesis Drives Therapy-Related Myeloid Neoplasms Following Autologous Stem Cell Transplantation and Propagates during Disease Evolution

Johannes Frasez Sørensen, Anni Aggerholm, Marcus H Hansen, MSc, Gitte Birk Kerndrup, MD DMSc, Lene Hyldahl Ebbesen, MD PhD, Peter Hokland, MD DMSc, Anne Stidsholt Roug, MD PhD, Maja Ludvigsen, MSc, PhD

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-141993

Published: 2020

Journal Articles

A 14q32.31 Genomic-Imprinted DLK1-DIO3 microrna promotes Leukemogenesis By Inducing Stem Cell Quiescence and Inhibiting NK Cell Anti-Cancer Immunity

Blood (2019) 134 (Supplement_1): 4141.

https://doi.org/10.1182/blood-2019-131113

Published: 2019

Journal Articles

Exploring Imaging Flow Cytometry As a Tool for Evaluating Dyserythropoiesis in Myelodysplastic Syndrome

Carina A Rosenberg, MSc, PhD, Marie Bill, MD PhD, Gitte Birk Kerndrup, MD DMSc, Mathias Hauerslev, Peter Hokland, MD DMSc, Maja Ludvigsen, MSc, PhD

Blood (2018) 132 (Supplement 1): 5508.

https://doi.org/10.1182/blood-2018-99-111555

Published: 2018

Journal Articles

Therapy-Related Myeloid Neoplasms Following Autologous Stem Cell Transplantation: The Prevalence of Chip Mutations at Time of Transplantation — a Single Center Experience

Johannes Frasez Soerensen, Anni Aggerholm, MSc, PhD, Gitte Birk Kerndrup, MD DMSc, Marcus C Hansen, MSc, Ina Kathrine Lykke Ewald, Lene Hyldahl Ebbesen, MD PhD, Carina A Rosenberg, MSc, PhD, Peter Hokland, MD DMSc, Anne Stidsholt Roug, MD Ass. Prof, Maja Ludvigsen, MSc, PhD

Blood (2018) 132 (Supplement 1): 1529.

https://doi.org/10.1182/blood-2018-99-114482

Published: 2018

Journal Articles

Clonal Progression during First Course of Chemotherapy in Acute Myeloid Leukemia Suboptimal Responders Heralds Reinduction Failure and Early Death

Anita Tranberg Simonsen, BSc, MSc, Manja Meggendorfer, PhD, Sarah Koch, Annette Fasan, PhD, Wolfgang Kern, MD, Line Nederby, MSc, PhD, Peter Hokland, MD, Hans Beier Ommen, MD PhD

Blood (2017) 130 (Supplement 1): 1418.

https://doi.org/10.1182/blood.V130.Suppl_1.1418.1418

Published: 2017

Journal Articles

The Bone Marrow Niche Uses Mir-300 As a Biological Rheostat to Selectively Control Stem Cell-Driven Malignant Hematopoiesis and Innate Anti-Cancer Immunity

Blood (2017) 130 (Supplement 1): 45.

https://doi.org/10.1182/blood.V130.Suppl_1.45.45

Published: 2017

Journal Articles

Whole Genome Amplification and Exome Sequencing at the Single Cell Level - a Way to Address Clonal Heterogeneity and Very Sparse Clinical Material

Peter Hokland, MD DMedSc, Professor, Anita T Simonsen, MSc, PhDStud., Marcus Celik Hansen, MSc, Biomedical Engineer, Johnny Juhl Hindkjær, MSc, PhD, Anni Aggerholm, PhD MSc

Blood (2016) 128 (22): 1671.

https://doi.org/10.1182/blood.V128.22.1671.1671

Published: 2016

Journal Articles

Role of the MSC-Derived Exosomal and Endogenous JAK2-SET/PP2A-Beta Catenin-Modulator Mir-300 in Leukemic Stem/Progenitor Proliferation and Survival in CML

Blood (2015) 126 (23): 53.

https://doi.org/10.1182/blood.V126.23.53.53

Published: 2015

Journal Articles

RNA-Sequencing of Cytogenetically Normal Acute Myeloid Leukemia to Extend Routine Molecular Diagnostics

Laura Laine Herborg, MD fellow, Marcus Celik Hansen, MSc in Biomedical Engineering, Maria Hansen, MSc, PhD, Anne Stidsholt Roug, MD PhD, Peter Hokland, MDD.MDSci, Professor

Blood (2015) 126 (23): 4969.

https://doi.org/10.1182/blood.V126.23.4969.4969

Published: 2015

Journal Articles

Strengthening the Evidence of Relevant Somatic Mutations of Individual Patients By Pairing Sequencing Deduced Allelic Burden, Leukemic Blast Percent and Cluster Analysis

Marcus Celik Hansen, MSc in Biomedical Engineering, Sadudee Chotirat, MD, Chirayu Udomsakdi Auewarakul, MD PhD Professor, Peter Hokland, MDD.MDSci, Professor

Blood (2015) 126 (23): 2589.

https://doi.org/10.1182/blood.V126.23.2589.2589

Published: 2015

Journal Articles

A New Approach to Identify Pathogenic Mutations and Inherited Variants By Exome Sequencing – Using a Pair of Identical Twins with Monoclonal Lymphosis As Case Model

Marcus Celik Hansen, MSc in Biomedical Engineering, Charlotte Guldborg Nyvold, MSc, PhD, Anne Stidsholt Roug, MD PhD, Line Nederby, MSc, PhD, Peter Hokland, MD DMSc

Blood (2014) 124 (21): 1979.

https://doi.org/10.1182/blood.V124.21.1979.1979

Published: 2014

Journal Articles

MiR-300 Acts As a Tumor Supressor in Ph+ Progenitors By Modulating the JAK2-SET/PP2A/β-Catenin Interplay

Giovannino Silvestri, PhD, Justin Ellis, Lorenzo Stramucci, PhD, Jason G Harb, PhD, Paolo Neviani, PhD, Guido Marcucci, MD, Denis-Claude Roy, MD, Peter Hokland, MD DMSc, Dragana Milojkovic, Alistair Reid, Jane F. Apperley, Ferenc M Livak, PhD, Maria R. Baer, MD, Rossana Trotta, PhD, Danilo Perrotti, MD PhD

Blood (2014) 124 (21): 4529.

https://doi.org/10.1182/blood.V124.21.4529.4529

Published: 2014

Journal Articles

SOX11, CCND1, BCL1/Igh, and Igh-VDJ – a Plethora of Markers for Minimal Residual Disease in Mantle Cell Lymphoma: Which One to Choose?

Anita Tranberg Simonsen, MSc., Marie Schou, Camilla Darum Sørensen, MSc., Peter Hokland, MD DMSc, Hans Bentzen, MD PhD, Charlotte Guldborg Nyvold, MSc, PhD

Blood (2014) 124 (21): 2957.

https://doi.org/10.1182/blood.V124.21.2957.2957

Published: 2014

Journal Articles

Relapse Kinetics in Acute Myeloid Leukemis Cases Encompassing More Than One Common Mutation: Towards a Unified Model

Hans Beier Ommen, MD PhD, Maria Hansen, MSc, PhD, Charlotte Guldborg Nyvold, MSc, PhD, Peter Hokland, MD DMSc

Blood (2014) 124 (21): 1055.

https://doi.org/10.1182/blood.V124.21.1055.1055

Published: 2014

Journal Articles

High Fractions of CD34+CD38- Cells with Aberrant hMICL Expression Predicts Shorter Overall- and Progression Free Survival in Myelodysplastic Syndrome

Marie Toft-Petersen, MD, Line Nederby, MSc, PhD, Peter Hokland, MD DMSc, Anne Stidsholt Roug, MD PhD

Blood (2014) 124 (21): 3235.

https://doi.org/10.1182/blood.V124.21.3235.3235

Published: 2014

Journal Articles

Characterisation of the Stem and Progenitor Cell Hierarchy in Patients with CMML

Onima Chowdhury, MD PhD, Petter S Woll, PhD, Una Kjällquist, PhD, Helen Doolittle, MD, Rikard Erlandsson, PhD, Kristina Anderson, MD PhD, Ingunn Dybedal, MD PhD, Adam Mead, MDPhD, Sally-Ann Clark, PhD, Mette S. Holm, MD PhD, Peter Hokland, MD DMSc, Lars Nilsson, MD PhD, Sten Linnarsson, PhD, Eva Hellstrom-Lindberg, MD PhD, Sten Eirik W Jacobsen, MD PhD

Blood (2014) 124 (21): 1896.

https://doi.org/10.1182/blood.V124.21.1896.1896

Published: 2014

Journal Articles

Cell Sorting Enables iFISH Detection Of Low BCR-ABL Producing Stem Cells In CML Patients Beyond Deep Molecular Remission

Peter Buur van Kooten Niekerk, MD, Charlotte Christie Petersen, MSc PhD, Charlotte Guldborg Nyvold, MSc, PhD, Hans Beier Ommen, MD, PhD, Anne Stidsholt Roug, MD, PhD, Line Nederby, MSc, PhD, Peter Hokland, MD, DMSC, Eigil Kjeldsen

Blood (2013) 122 (21): 1501.

https://doi.org/10.1182/blood.V122.21.1501.1501

Published: 2013

Journal Articles

Human MICL Is An Early Marker In Myeloid Differentiation and Identifies a Subgroup Of CML Patients With Expanded Granulocyte-Macrophage Progenitor Populations At Diagnosis

Peter Buur van Kooten Niekerk, MD, Anne Stidsholt Roug, MD, PhD, Charlotte Christie Petersen, MSc PhD, Line Nederby, MSc, PhD, Charlotte Guldborg Nyvold, MSc, PhD, Ole Weis Bjerrum, MD, Andreja Dimitrijevic, MD, Marianne T. Severinsen, MD, PhD, Jesper Stentoft, MD, PhD, Peter Hokland, MD, DMSC

Blood (2013) 122 (21): 2704.

https://doi.org/10.1182/blood.V122.21.2704.2704

Published: 2013

Journal Articles

Two Hematological Pre-Malignancies In a Pair Of Homozygous Twins Revealing Differences In Their Pre- and Postnatal Development

Peter Hokland, M.D. D. Med. Sci., Anne Stidsholt Roug, MD, Line Nederby, MSc, PhD, Eigil Kjeldsen, MD, Palle Villesen, M.Sc. Ph.D., Charlotte Guldborg Nyvold, MSc, PhD

Blood (2013) 122 (21): 5262.

https://doi.org/10.1182/blood.V122.21.5262.5262

Published: 2013

Journal Articles

Diverse Genetic Lesions In Myelodysplastic Syndromes Originate Exclusively In Rare MDS Stem Cells

Blood (2013) 122 (21): 4195.

https://doi.org/10.1182/blood.V122.21.4195.4195

Published: 2013

NARROW

Clonal Hematopoiesis Drives Therapy-Related Myeloid Neoplasms Following Autologous Stem Cell Transplantation and Propagates during Disease Evolution

A 14q32.31 Genomic-Imprinted DLK1-DIO3 microrna promotes Leukemogenesis By Inducing Stem Cell Quiescence and Inhibiting NK Cell Anti-Cancer Immunity

Exploring Imaging Flow Cytometry As a Tool for Evaluating Dyserythropoiesis in Myelodysplastic Syndrome

Therapy-Related Myeloid Neoplasms Following Autologous Stem Cell Transplantation: The Prevalence of Chip Mutations at Time of Transplantation — a Single Center Experience

Clonal Progression during First Course of Chemotherapy in Acute Myeloid Leukemia Suboptimal Responders Heralds Reinduction Failure and Early Death

The Bone Marrow Niche Uses Mir-300 As a Biological Rheostat to Selectively Control Stem Cell-Driven Malignant Hematopoiesis and Innate Anti-Cancer Immunity

Whole Genome Amplification and Exome Sequencing at the Single Cell Level - a Way to Address Clonal Heterogeneity and Very Sparse Clinical Material

Role of the MSC-Derived Exosomal and Endogenous JAK2-SET/PP2A-Beta Catenin-Modulator Mir-300 in Leukemic Stem/Progenitor Proliferation and Survival in CML

RNA-Sequencing of Cytogenetically Normal Acute Myeloid Leukemia to Extend Routine Molecular Diagnostics

Strengthening the Evidence of Relevant Somatic Mutations of Individual Patients By Pairing Sequencing Deduced Allelic Burden, Leukemic Blast Percent and Cluster Analysis

A New Approach to Identify Pathogenic Mutations and Inherited Variants By Exome Sequencing – Using a Pair of Identical Twins with Monoclonal Lymphosis As Case Model

MiR-300 Acts As a Tumor Supressor in Ph+ Progenitors By Modulating the JAK2-SET/PP2A/β-Catenin Interplay

SOX11, CCND1, BCL1/Igh, and Igh-VDJ – a Plethora of Markers for Minimal Residual Disease in Mantle Cell Lymphoma: Which One to Choose?

Relapse Kinetics in Acute Myeloid Leukemis Cases Encompassing More Than One Common Mutation: Towards a Unified Model

High Fractions of CD34+CD38- Cells with Aberrant hMICL Expression Predicts Shorter Overall- and Progression Free Survival in Myelodysplastic Syndrome

Characterisation of the Stem and Progenitor Cell Hierarchy in Patients with CMML

Cell Sorting Enables iFISH Detection Of Low BCR-ABL Producing Stem Cells In CML Patients Beyond Deep Molecular Remission

Human MICL Is An Early Marker In Myeloid Differentiation and Identifies a Subgroup Of CML Patients With Expanded Granulocyte-Macrophage Progenitor Populations At Diagnosis

Two Hematological Pre-Malignancies In a Pair Of Homozygous Twins Revealing Differences In Their Pre- and Postnatal Development

Diverse Genetic Lesions In Myelodysplastic Syndromes Originate Exclusively In Rare MDS Stem Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only